Literature DB >> 8423392

Mechanisms of UV-induced inflammation.

L L Hruza1, A P Pentland.   

Abstract

The inflammation produced by exposure to ultraviolet (UV) light has been well documented clinically and histologically. However, the mechanisms by which mediators induce this clinical response remain poorly defined. It is clear that photochemistry occurring after UV absorption must be responsible for initiating these events. Some of these underlying mechanisms have been defined. After exposure to UV light, the formation of prostaglandins and the release of histamine are increased. In addition to an increase in the quantity of these mediators, an increase in sensitivity of irradiated tissue to agonist stimulation also occurs. This increased sensitivity may cause tissue to respond to agonist levels previously present. Phospholipase activity also increases, making more substrate available for prostaglandin formation. Oxygen radical-induced peroxidation of membrane lipids caused by irradiation may contribute to increased phospholipase activity. Oxygen-free radicals also participate in sunburn cell formation and in UV-induced decreases in Langerhans cell numbers. Several enzymatic and non-enzymatic mechanisms are present in skin for reducing these highly reactive oxygen species.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423392     DOI: 10.1111/1523-1747.ep12355240

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  54 in total

1.  Modulation of ultraviolet-induced hyperalgesia and cytokine upregulation by interleukins 10 and 13.

Authors:  N E Saadé; I W Nasr; C A Massaad; B Safieh-Garabedian; S J Jabbur; S A Kanaan
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis.

Authors:  Susan M Fischer; Amy Pavone; Carol Mikulec; Robert Langenbach; Joyce E Rundhaug
Journal:  Mol Carcinog       Date:  2007-05       Impact factor: 4.784

3.  Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study.

Authors:  E Bangha; P Elsner; G S Kistler
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

4.  Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.

Authors:  Amelia Grover; Grace J Kim; Gregory Lizée; Mary Tschoi; Gang Wang; John R Wunderlich; Steven A Rosenberg; Sam T Hwang; Patrick Hwu
Journal:  Clin Cancer Res       Date:  2006-10-01       Impact factor: 12.531

Review 5.  Stress, aging, and brain oxidative damage.

Authors:  J Liu; A Mori
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

6.  The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing.

Authors:  Traci A Wilgus; Valerie K Bergdall; Kathleen L Tober; Kara J Hill; Srabani Mitra; Nicholas A Flavahan; Tatiana M Oberyszyn
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 7.  Grape seed proanthocyanidines and skin cancer prevention: inhibition of oxidative stress and protection of immune system.

Authors:  Santosh K Katiyar
Journal:  Mol Nutr Food Res       Date:  2008-06       Impact factor: 5.914

8.  Prevention of UV-induced skin damages by 11,14,17-eicosatrienoic acid in hairless mice in vivo.

Authors:  Xing-Ji Jin; Eun Ju Kim; In Kyung Oh; Yeon Kyung Kim; Chi-Hyun Park; Jin Ho Chung
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

Review 9.  Use of sensory methods for detecting target engagement in clinical trials of new analgesics.

Authors:  Boris A Chizh; Christine N Sang
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  The chemopreventive efficacies of nonsteroidal anti-inflammatory drugs: the relationship of short-term biomarkers to long-term skin tumor outcome.

Authors:  Carol D Mikulec; Joyce E Rundhaug; Melissa S Simper; Ronald A Lubet; Susan M Fischer
Journal:  Cancer Prev Res (Phila)       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.